Gynecology Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy); Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, and Contraception); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
Report Code: TIPRE00003487 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Gynecological diseases are type of medical conditions which is precise to the female reproductive system. Therefore, gynecological diseases include conditions affecting the uterus, ovaries and their appendages. Gynecology drugs are the therapeutics developed for the treatment of various gynecological diseases and symptoms. Dependable rise in awareness about health and well-being has increased the demand for better gynecological treatments. Due to this, various drug manufacturers across the globe have formulated more innovative gynecology therapeutics having better effectiveness and lowered side-effects.
MARKET DYNAMICS
The gynecology drugs market is anticipated to grow in the forecast period owing to driving factors such as increase in incidence of gynecological diseases, change in lifestyle of the global female population, and rise in the demand for better gynecological treatments. However, the stringent regulations and high-quality standards set by market leaders are projected to restrain the penetration of new entrants, which eventually hinders the market growth.
MARKET SCOPE
The "Global Gynecology Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of gynecology drugs market with detailed market segmentation by therapeutics, indication, distribution channel, and geography. The global gynecology drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading gynecology drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global gynecology drugs market is segmented on the basis of therapeutics, indication and distribution channel. Based on therapeutics, the market is segmented as hormonal therapy and non-hormonal therapy. The gynecology drugs market, based on indication is segmented into gynecology cancers, endometriosis, female infertility, menopausal disorder, gynecology infections, polycystic ovary syndrome, and contraception. By distribution channel the gynecology drugs market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global gynecology drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gynecology drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting gynecology drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gynecology drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the gynecology drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from gynecology drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for gynecology drugs market in the global market. Below mentioned is the list of few companies engaged in the gynecology drugs market.
The report also includes the profiles of key gynecology drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Gynecological diseases are type of medical conditions which is precise to the female reproductive system. Therefore, gynecological diseases include conditions affecting the uterus, ovaries and their appendages. Gynecology drugs are the therapeutics developed for the treatment of various gynecological diseases and symptoms. Dependable rise in awareness about health and well-being has increased the demand for better gynecological treatments. Due to this, various drug manufacturers across the globe have formulated more innovative gynecology therapeutics having better effectiveness and lowered side-effects.
MARKET DYNAMICS
The gynecology drugs market is anticipated to grow in the forecast period owing to driving factors such as increase in incidence of gynecological diseases, change in lifestyle of the global female population, and rise in the demand for better gynecological treatments. However, the stringent regulations and high-quality standards set by market leaders are projected to restrain the penetration of new entrants, which eventually hinders the market growth.
MARKET SCOPE
The "Global Gynecology Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of gynecology drugs market with detailed market segmentation by therapeutics, indication, distribution channel, and geography. The global gynecology drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading gynecology drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global gynecology drugs market is segmented on the basis of therapeutics, indication and distribution channel. Based on therapeutics, the market is segmented as hormonal therapy and non-hormonal therapy. The gynecology drugs market, based on indication is segmented into gynecology cancers, endometriosis, female infertility, menopausal disorder, gynecology infections, polycystic ovary syndrome, and contraception. By distribution channel the gynecology drugs market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global gynecology drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gynecology drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting gynecology drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gynecology drugs market in these regions.
MARKET PLAYERS
The reports cover key developments in the gynecology drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from gynecology drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for gynecology drugs market in the global market. Below mentioned is the list of few companies engaged in the gynecology drugs market.
The report also includes the profiles of key gynecology drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Eli Lilly and Company
- Pfizer Inc.
- Merck & Co., Inc.
- Amgen Inc.
- AstraZeneca
- F. Hoffmann-La Roche Ltd.
- Allergan Plc.
- Bayer AG
- Abbott
- AbbVie
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gynecology Drugs Market - By Therapeutics
1.3.2 Gynecology Drugs Market - By Indication
1.3.3 Gynecology Drugs Market - By Distribution Channel
1.3.4 Gynecology Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. GYNECOLOGY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GYNECOLOGY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GYNECOLOGY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GYNECOLOGY DRUGS - GLOBAL MARKET OVERVIEW
6.2. GYNECOLOGY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GYNECOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. HORMONAL THERAPY
7.3.1. Overview
7.3.2. Hormonal Therapy Market Forecast and Analysis
7.4. NON-HORMONAL THERAPY
7.4.1. Overview
7.4.2. Non-Hormonal Therapy Market Forecast and Analysis
8. GYNECOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. GYNECOLOGY CANCERS
8.3.1. Overview
8.3.2. Gynecology Cancers Market Forecast and Analysis
8.4. ENDOMETRIOSIS
8.4.1. Overview
8.4.2. Endometriosis Market Forecast and Analysis
8.5. FEMALE INFERTILITY
8.5.1. Overview
8.5.2. Female Infertility Market Forecast and Analysis
8.6. MENOPAUSAL DISORDER
8.6.1. Overview
8.6.2. Menopausal Disorder Market Forecast and Analysis
8.7. GYNECOLOGY INFECTIONS
8.7.1. Overview
8.7.2. Gynecology Infections Market Forecast and Analysis
8.8. POLYCYSTIC OVARY SYNDROME
8.8.1. Overview
8.8.2. Polycystic Ovary Syndrome Market Forecast and Analysis
8.9. CONTRACEPTION
8.9.1. Overview
8.9.2. Contraception Market Forecast and Analysis
9. GYNECOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. GYNECOLOGY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Gynecology Drugs Market Overview
10.1.2 North America Gynecology Drugs Market Forecasts and Analysis
10.1.3 North America Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.1.4 North America Gynecology Drugs Market Forecasts and Analysis - By Indication
10.1.5 North America Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Gynecology Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Gynecology Drugs Market
10.1.6.1.1 United States Gynecology Drugs Market by Therapeutics
10.1.6.1.2 United States Gynecology Drugs Market by Indication
10.1.6.1.3 United States Gynecology Drugs Market by Distribution Channel
10.1.6.2 Canada Gynecology Drugs Market
10.1.6.2.1 Canada Gynecology Drugs Market by Therapeutics
10.1.6.2.2 Canada Gynecology Drugs Market by Indication
10.1.6.2.3 Canada Gynecology Drugs Market by Distribution Channel
10.1.6.3 Mexico Gynecology Drugs Market
10.1.6.3.1 Mexico Gynecology Drugs Market by Therapeutics
10.1.6.3.2 Mexico Gynecology Drugs Market by Indication
10.1.6.3.3 Mexico Gynecology Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Gynecology Drugs Market Overview
10.2.2 Europe Gynecology Drugs Market Forecasts and Analysis
10.2.3 Europe Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.2.4 Europe Gynecology Drugs Market Forecasts and Analysis - By Indication
10.2.5 Europe Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Gynecology Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Gynecology Drugs Market
10.2.6.1.1 Germany Gynecology Drugs Market by Therapeutics
10.2.6.1.2 Germany Gynecology Drugs Market by Indication
10.2.6.1.3 Germany Gynecology Drugs Market by Distribution Channel
10.2.6.2 France Gynecology Drugs Market
10.2.6.2.1 France Gynecology Drugs Market by Therapeutics
10.2.6.2.2 France Gynecology Drugs Market by Indication
10.2.6.2.3 France Gynecology Drugs Market by Distribution Channel
10.2.6.3 Italy Gynecology Drugs Market
10.2.6.3.1 Italy Gynecology Drugs Market by Therapeutics
10.2.6.3.2 Italy Gynecology Drugs Market by Indication
10.2.6.3.3 Italy Gynecology Drugs Market by Distribution Channel
10.2.6.4 Spain Gynecology Drugs Market
10.2.6.4.1 Spain Gynecology Drugs Market by Therapeutics
10.2.6.4.2 Spain Gynecology Drugs Market by Indication
10.2.6.4.3 Spain Gynecology Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Gynecology Drugs Market
10.2.6.5.1 United Kingdom Gynecology Drugs Market by Therapeutics
10.2.6.5.2 United Kingdom Gynecology Drugs Market by Indication
10.2.6.5.3 United Kingdom Gynecology Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Gynecology Drugs Market Overview
10.3.2 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.3.4 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Gynecology Drugs Market
10.3.6.1.1 Australia Gynecology Drugs Market by Therapeutics
10.3.6.1.2 Australia Gynecology Drugs Market by Indication
10.3.6.1.3 Australia Gynecology Drugs Market by Distribution Channel
10.3.6.2 China Gynecology Drugs Market
10.3.6.2.1 China Gynecology Drugs Market by Therapeutics
10.3.6.2.2 China Gynecology Drugs Market by Indication
10.3.6.2.3 China Gynecology Drugs Market by Distribution Channel
10.3.6.3 India Gynecology Drugs Market
10.3.6.3.1 India Gynecology Drugs Market by Therapeutics
10.3.6.3.2 India Gynecology Drugs Market by Indication
10.3.6.3.3 India Gynecology Drugs Market by Distribution Channel
10.3.6.4 Japan Gynecology Drugs Market
10.3.6.4.1 Japan Gynecology Drugs Market by Therapeutics
10.3.6.4.2 Japan Gynecology Drugs Market by Indication
10.3.6.4.3 Japan Gynecology Drugs Market by Distribution Channel
10.3.6.5 South Korea Gynecology Drugs Market
10.3.6.5.1 South Korea Gynecology Drugs Market by Therapeutics
10.3.6.5.2 South Korea Gynecology Drugs Market by Indication
10.3.6.5.3 South Korea Gynecology Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Gynecology Drugs Market Overview
10.4.2 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.4.4 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Gynecology Drugs Market
10.4.6.1.1 South Africa Gynecology Drugs Market by Therapeutics
10.4.6.1.2 South Africa Gynecology Drugs Market by Indication
10.4.6.1.3 South Africa Gynecology Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Gynecology Drugs Market
10.4.6.2.1 Saudi Arabia Gynecology Drugs Market by Therapeutics
10.4.6.2.2 Saudi Arabia Gynecology Drugs Market by Indication
10.4.6.2.3 Saudi Arabia Gynecology Drugs Market by Distribution Channel
10.4.6.3 U.A.E Gynecology Drugs Market
10.4.6.3.1 U.A.E Gynecology Drugs Market by Therapeutics
10.4.6.3.2 U.A.E Gynecology Drugs Market by Indication
10.4.6.3.3 U.A.E Gynecology Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Gynecology Drugs Market Overview
10.5.2 South and Central America Gynecology Drugs Market Forecasts and Analysis
10.5.3 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.5.4 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Gynecology Drugs Market
10.5.6.1.1 Brazil Gynecology Drugs Market by Therapeutics
10.5.6.1.2 Brazil Gynecology Drugs Market by Indication
10.5.6.1.3 Brazil Gynecology Drugs Market by Distribution Channel
10.5.6.2 Argentina Gynecology Drugs Market
10.5.6.2.1 Argentina Gynecology Drugs Market by Therapeutics
10.5.6.2.2 Argentina Gynecology Drugs Market by Indication
10.5.6.2.3 Argentina Gynecology Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GYNECOLOGY DRUGS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK & CO., INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AMGEN INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ALLERGAN PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BAYER AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ABBOTT
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ABBVIE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gynecology Drugs Market - By Therapeutics
1.3.2 Gynecology Drugs Market - By Indication
1.3.3 Gynecology Drugs Market - By Distribution Channel
1.3.4 Gynecology Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. GYNECOLOGY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GYNECOLOGY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GYNECOLOGY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GYNECOLOGY DRUGS - GLOBAL MARKET OVERVIEW
6.2. GYNECOLOGY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GYNECOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. HORMONAL THERAPY
7.3.1. Overview
7.3.2. Hormonal Therapy Market Forecast and Analysis
7.4. NON-HORMONAL THERAPY
7.4.1. Overview
7.4.2. Non-Hormonal Therapy Market Forecast and Analysis
8. GYNECOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. GYNECOLOGY CANCERS
8.3.1. Overview
8.3.2. Gynecology Cancers Market Forecast and Analysis
8.4. ENDOMETRIOSIS
8.4.1. Overview
8.4.2. Endometriosis Market Forecast and Analysis
8.5. FEMALE INFERTILITY
8.5.1. Overview
8.5.2. Female Infertility Market Forecast and Analysis
8.6. MENOPAUSAL DISORDER
8.6.1. Overview
8.6.2. Menopausal Disorder Market Forecast and Analysis
8.7. GYNECOLOGY INFECTIONS
8.7.1. Overview
8.7.2. Gynecology Infections Market Forecast and Analysis
8.8. POLYCYSTIC OVARY SYNDROME
8.8.1. Overview
8.8.2. Polycystic Ovary Syndrome Market Forecast and Analysis
8.9. CONTRACEPTION
8.9.1. Overview
8.9.2. Contraception Market Forecast and Analysis
9. GYNECOLOGY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. GYNECOLOGY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Gynecology Drugs Market Overview
10.1.2 North America Gynecology Drugs Market Forecasts and Analysis
10.1.3 North America Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.1.4 North America Gynecology Drugs Market Forecasts and Analysis - By Indication
10.1.5 North America Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Gynecology Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Gynecology Drugs Market
10.1.6.1.1 United States Gynecology Drugs Market by Therapeutics
10.1.6.1.2 United States Gynecology Drugs Market by Indication
10.1.6.1.3 United States Gynecology Drugs Market by Distribution Channel
10.1.6.2 Canada Gynecology Drugs Market
10.1.6.2.1 Canada Gynecology Drugs Market by Therapeutics
10.1.6.2.2 Canada Gynecology Drugs Market by Indication
10.1.6.2.3 Canada Gynecology Drugs Market by Distribution Channel
10.1.6.3 Mexico Gynecology Drugs Market
10.1.6.3.1 Mexico Gynecology Drugs Market by Therapeutics
10.1.6.3.2 Mexico Gynecology Drugs Market by Indication
10.1.6.3.3 Mexico Gynecology Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Gynecology Drugs Market Overview
10.2.2 Europe Gynecology Drugs Market Forecasts and Analysis
10.2.3 Europe Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.2.4 Europe Gynecology Drugs Market Forecasts and Analysis - By Indication
10.2.5 Europe Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Gynecology Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Gynecology Drugs Market
10.2.6.1.1 Germany Gynecology Drugs Market by Therapeutics
10.2.6.1.2 Germany Gynecology Drugs Market by Indication
10.2.6.1.3 Germany Gynecology Drugs Market by Distribution Channel
10.2.6.2 France Gynecology Drugs Market
10.2.6.2.1 France Gynecology Drugs Market by Therapeutics
10.2.6.2.2 France Gynecology Drugs Market by Indication
10.2.6.2.3 France Gynecology Drugs Market by Distribution Channel
10.2.6.3 Italy Gynecology Drugs Market
10.2.6.3.1 Italy Gynecology Drugs Market by Therapeutics
10.2.6.3.2 Italy Gynecology Drugs Market by Indication
10.2.6.3.3 Italy Gynecology Drugs Market by Distribution Channel
10.2.6.4 Spain Gynecology Drugs Market
10.2.6.4.1 Spain Gynecology Drugs Market by Therapeutics
10.2.6.4.2 Spain Gynecology Drugs Market by Indication
10.2.6.4.3 Spain Gynecology Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Gynecology Drugs Market
10.2.6.5.1 United Kingdom Gynecology Drugs Market by Therapeutics
10.2.6.5.2 United Kingdom Gynecology Drugs Market by Indication
10.2.6.5.3 United Kingdom Gynecology Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Gynecology Drugs Market Overview
10.3.2 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.3.4 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Gynecology Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Gynecology Drugs Market
10.3.6.1.1 Australia Gynecology Drugs Market by Therapeutics
10.3.6.1.2 Australia Gynecology Drugs Market by Indication
10.3.6.1.3 Australia Gynecology Drugs Market by Distribution Channel
10.3.6.2 China Gynecology Drugs Market
10.3.6.2.1 China Gynecology Drugs Market by Therapeutics
10.3.6.2.2 China Gynecology Drugs Market by Indication
10.3.6.2.3 China Gynecology Drugs Market by Distribution Channel
10.3.6.3 India Gynecology Drugs Market
10.3.6.3.1 India Gynecology Drugs Market by Therapeutics
10.3.6.3.2 India Gynecology Drugs Market by Indication
10.3.6.3.3 India Gynecology Drugs Market by Distribution Channel
10.3.6.4 Japan Gynecology Drugs Market
10.3.6.4.1 Japan Gynecology Drugs Market by Therapeutics
10.3.6.4.2 Japan Gynecology Drugs Market by Indication
10.3.6.4.3 Japan Gynecology Drugs Market by Distribution Channel
10.3.6.5 South Korea Gynecology Drugs Market
10.3.6.5.1 South Korea Gynecology Drugs Market by Therapeutics
10.3.6.5.2 South Korea Gynecology Drugs Market by Indication
10.3.6.5.3 South Korea Gynecology Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Gynecology Drugs Market Overview
10.4.2 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.4.4 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Gynecology Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Gynecology Drugs Market
10.4.6.1.1 South Africa Gynecology Drugs Market by Therapeutics
10.4.6.1.2 South Africa Gynecology Drugs Market by Indication
10.4.6.1.3 South Africa Gynecology Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Gynecology Drugs Market
10.4.6.2.1 Saudi Arabia Gynecology Drugs Market by Therapeutics
10.4.6.2.2 Saudi Arabia Gynecology Drugs Market by Indication
10.4.6.2.3 Saudi Arabia Gynecology Drugs Market by Distribution Channel
10.4.6.3 U.A.E Gynecology Drugs Market
10.4.6.3.1 U.A.E Gynecology Drugs Market by Therapeutics
10.4.6.3.2 U.A.E Gynecology Drugs Market by Indication
10.4.6.3.3 U.A.E Gynecology Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Gynecology Drugs Market Overview
10.5.2 South and Central America Gynecology Drugs Market Forecasts and Analysis
10.5.3 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Therapeutics
10.5.4 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Gynecology Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Gynecology Drugs Market
10.5.6.1.1 Brazil Gynecology Drugs Market by Therapeutics
10.5.6.1.2 Brazil Gynecology Drugs Market by Indication
10.5.6.1.3 Brazil Gynecology Drugs Market by Distribution Channel
10.5.6.2 Argentina Gynecology Drugs Market
10.5.6.2.1 Argentina Gynecology Drugs Market by Therapeutics
10.5.6.2.2 Argentina Gynecology Drugs Market by Indication
10.5.6.2.3 Argentina Gynecology Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GYNECOLOGY DRUGS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK & CO., INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AMGEN INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ALLERGAN PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BAYER AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ABBOTT
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ABBVIE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Eli Lilly and Company
2. Pfizer Inc.
3. Merck & Co., Inc.
4. Amgen Inc.
5. AstraZeneca
6. F. Hoffmann-La Roche Ltd.
7. Allergan Plc.
8. Bayer AG
9. Abbott
10. AbbVie
1. Eli Lilly and Company
2. Pfizer Inc.
3. Merck & Co., Inc.
4. Amgen Inc.
5. AstraZeneca
6. F. Hoffmann-La Roche Ltd.
7. Allergan Plc.
8. Bayer AG
9. Abbott
10. AbbVie